These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10368448)

  • 1. Effects of gamma-globulin on the cardiac sequelae of Kawasaki disease.
    Yanagawa H; Tuohong Z; Oki I; Nakamura Y; Yashiro M; Ojima T; Tanihara S
    Pediatr Cardiol; 1999; 20(4):248-51. PubMed ID: 10368448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors related to cardiac sequelae of Kawasaki disease.
    Zhang T; Yanagawa H; Oki I; Nakamura Y; Yashiro M; Ojima T; Tanihara S
    Eur J Pediatr; 1999 Sep; 158(9):694-7. PubMed ID: 10485297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac sequelae of Kawasaki disease in Japan: statistical analysis.
    Nakamura Y; Fujita Y; Nagai M; Yanagawa H; Imada Y; Okawa S; Kawasaki T; Kato H
    Pediatrics; 1991 Dec; 88(6):1144-7. PubMed ID: 1720235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors relating to the cardiac sequelae of Kawasaki disease one month after initial onset.
    Zhang T; Yanagawa H; Oki I; Nakamura Y
    Acta Paediatr; 2002; 91(5):517-20. PubMed ID: 12113319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early intravenous gamma-globulin treatment for Kawasaki disease: the nationwide surveys in Japan.
    Muta H; Ishii M; Egami K; Furui J; Sugahara Y; Akagi T; Nakamura Y; Yanagawa H; Matsuishi T
    J Pediatr; 2004 Apr; 144(4):496-9. PubMed ID: 15069399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of Kawasaki disease in Japan: the nationwide surveys of 1999-2002.
    Yanagawa H; Nakamura Y; Yashiro M; Uehara R; Oki I; Kayaba K
    Pediatr Int; 2006 Aug; 48(4):356-61. PubMed ID: 16911079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nationwide survey on Kawasaki disease in Japan.
    Yanagawa H; Kawasaki T; Shigematsu I
    Pediatrics; 1987 Jul; 80(1):58-62. PubMed ID: 3601519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case-control study of giant coronary aneurysms due to Kawasaki disease: the 19th nationwide survey.
    Sudo D; Monobe Y; Yashiro M; Sadakane A; Uehara R; Nakamura Y
    Pediatr Int; 2010 Oct; 52(5):790-4. PubMed ID: 20487371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors associated with the need for additional intravenous gamma-globulin therapy for Kawasaki disease.
    Muta H; Ishii M; Furui J; Nakamura Y; Matsuishi T
    Acta Paediatr; 2006 Feb; 95(2):189-93. PubMed ID: 16449025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of intravenous gamma-globulin for Kawasaki disease: effects on cardiac sequelae.
    Yanagawa H; Nakamura Y; Sakata K; Yashiro M
    Pediatr Cardiol; 1997; 18(1):19-23. PubMed ID: 8960487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac lesions and initial laboratory data in Kawasaki disease: a nationwide survey in Japan.
    Kuwabara M; Yashiro M; Kotani K; Tsuboi S; Ae R; Nakamura Y; Yanagawa H; Kawasaki T
    J Epidemiol; 2015; 25(3):189-93. PubMed ID: 25716055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical relevance of the risk factors for coronary artery inflammation in Kawasaki disease.
    Honkanen VE; McCrindle BW; Laxer RM; Feldman BM; Schneider R; Silverman ED
    Pediatr Cardiol; 2003; 24(2):122-6. PubMed ID: 12457252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing incidence of Kawasaki disease in Japan: nationwide survey.
    Nakamura Y; Yashiro M; Uehara R; Oki I; Kayaba K; Yanagawa H
    Pediatr Int; 2008 Jun; 50(3):287-90. PubMed ID: 18533938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early intravenous gamma-globulin treatment for Kawasaki disease: the nationwide surveys in Japan.
    Wanitkun S
    J Pediatr; 2005 Jan; 146(1):149-50; author reply 150-1. PubMed ID: 15644851
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum alanine aminotransferase concentrations in patients with Kawasaki disease.
    Uehara R; Yashiro M; Hayasaka S; Oki I; Nakamura Y; Muta H; Ishii M; Matsuishi T; Sonobe T; Yanagawa H
    Pediatr Infect Dis J; 2003 Sep; 22(9):839-42. PubMed ID: 14515833
    [No Abstract]   [Full Text] [Related]  

  • 16. Results of the nationwide epidemiologic survey of Kawasaki disease in 1995 and 1996 in Japan.
    Yanagawa H; Nakamura Y; Yashiro M; Ojima T; Tanihara S; Oki I; Zhang T
    Pediatrics; 1998 Dec; 102(6):E65. PubMed ID: 9832593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iv gamma globulin treatment of Kawasaki disease in Japan: results of a nationwide survey.
    Yanagawa H; Yashiro M; Nakamura Y; Sakata K; Kawasaki T
    Acta Paediatr; 1995 Jul; 84(7):765-8. PubMed ID: 7549294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiologic pictures of Kawasaki disease in Japan: from the nationwide incidence survey in 1991 and 1992.
    Yanagawa H; Yashiro M; Nakamura Y; Kawasaki T; Kato H
    Pediatrics; 1995 Apr; 95(4):475-9. PubMed ID: 7700743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac sequelae in recurrent cases of Kawasaki disease: a comparison between the initial episode of the disease and a recurrence in the same patients.
    Nakamura Y; Oki I; Tanihara S; Ojima T; Yanagawa H
    Pediatrics; 1998 Dec; 102(6):E66. PubMed ID: 9832594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicenter collaborative study on the risk factors of cardiac sequelae due to Kawasaki disease: a one-year follow-up study.
    Oki I; Tanihara S; Ojima T; Nakamura Y; Yanagawa H
    Acta Paediatr; 2000 Dec; 89(12):1435-8. PubMed ID: 11195232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.